Prostate Cancer Therapy
Studies from University of Rochester yield new data on prostate cancer therapy
Published in Gene Therapy Weekly, January 29th, 2009
Fresh data on prostate cancer are presented in the report 'RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects.' In this recently published article, scientists in the United States conducted a study "To determine the antitumor efficacy of using calcitriol combined with RRR-alpha-vitamin E succinate (VES) on prostate cancer. The effects of VES or VES in combination with calcitriol on the calcitriol target genes were evaluated by Western blot and real-time PCR."
"The antiproliferation effect of the combination in prostate cancer cells was evaluated by the combination index method. The role of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2009-01-29)
More Articles from Gene Therapy Weekly
- Adenocarcinoma
New findings from Xi'an Jiao Tong University in the area of adenocarcinoma described - Adenovirus
Researchers at Chinese University of Hong Kong target adenovirus - Apoptosis
Studies from J.W. Huang et al have provided new data on apoptosis - Basal Cell Cancer
Investigators at University of Munich target basal cell cancer - Brain Cancer
New research on brain cancer from Brain Tumor Center summarized - Breast Cancer
Researchers from University of Bern detail findings in breast cancer - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
